CN Patent

CN111050798A — 用于治疗真菌感染的组合物和方法

Assigned to Nap Pharmaceutical Group Co ltd · Expires 2020-04-21 · 6y expired

What this patent protects

本公开的特征在于非刺激性药物组合物，其含有呈药学上可接受的盐(例如，CD101醋酸盐)或中性形式的CD101。可以将所述药物组合物静脉内施用于受试者以治疗所述该受试者的真菌感染(例如念珠菌病)。

USPTO Abstract

本公开的特征在于非刺激性药物组合物，其含有呈药学上可接受的盐(例如，CD101醋酸盐)或中性形式的CD101。可以将所述药物组合物静脉内施用于受试者以治疗所述该受试者的真菌感染(例如念珠菌病)。

Drugs covered by this patent

Patent Metadata

Patent number
CN111050798A
Jurisdiction
CN
Classification
—
Expires
2020-04-21
Drug substance claim
No
Drug product claim
No
Assignee
Nap Pharmaceutical Group Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.